Nakamura Tsutomu, Sakaeda Toshiyuki, Horinouchi Masanori, Tamura Takao, Aoyama Nobuo, Shirakawa Toshiro, Matsuo Masafumi, Kasuga Masato, Okumura Katsuhiko
Department of Hospital Pharmacy, School of Medicine, Kobe University, Japan.
Clin Pharmacol Ther. 2002 Apr;71(4):297-303. doi: 10.1067/mcp.2002.122055.
The effect of the C3435T mutation at exon 26 of the MDR1 gene on the expression levels of MDR1 messenger ribonucleic acid (mRNA) was evaluated by means of real-time polymerase chain reaction in 51 biopsy specimens of duodenum obtained from 13 healthy Japanese subjects. The mRNA levels of MDR1 were 0.38 +/- 0.15, 0.56 +/- 0.14, and 1.13 +/- 0.42 (mean value +/- SE) in the subjects with the homozygote of wild-type allele (C/C), compound heterozygote with mutant T allele (C/T), and the homozygote of the mutant allele (T/T), respectively, reasonably explaining the lower digoxin serum concentration after administration of a single oral dose to subjects harboring a mutant T allele. Good correlation (r =.797; P <.01) was observed between the mRNA concentrations of MDR1 and CYP3A4 in the individual biopsy specimens. This finding suggested a lower plasma concentration of the substrates for CYP3A4 in subjects harboring the C3435T mutation of the MDR1 gene.
采用实时聚合酶链反应,对13名健康日本受试者的51份十二指肠活检标本进行检测,评估多药耐药基因1(MDR1)第26外显子C3435T突变对MDR1信使核糖核酸(mRNA)表达水平的影响。野生型等位基因纯合子(C/C)、携带突变T等位基因的复合杂合子(C/T)以及突变等位基因纯合子(T/T)受试者的MDR1 mRNA水平分别为0.38±0.15、0.56±0.14和1.13±0.42(平均值±标准误),这合理地解释了携带突变T等位基因的受试者单次口服给药后地高辛血清浓度较低的现象。在个体活检标本中,观察到MDR1和细胞色素P450 3A4(CYP3A4)的mRNA浓度之间具有良好的相关性(r = 0.797;P < 0.01)。这一发现表明,携带MDR1基因C3435T突变的受试者中,CYP3A4底物的血浆浓度较低。